Market Overview:
The global small animals respiratory diseases treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of respiratory diseases in small animals, rising awareness about pet health, and growing demand for advanced veterinary care. Based on type, the global small animals respiratory diseases treatment market is segmented into anthelmintics, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, antibiotics, antihistamines, phosphodiesterase (PDE) inhibitors, bronchodilators and antineoplastic agents. The antibiotics segment is expected to grow at the highest CAGR during the forecast period owing to rising incidence of bacterial infections in small animals. Based on application, the global small animals respiratory diseases treatment market is segmented into allergic pneumonitis,, canine influenza,, canine nasal mites,, lung nematodes,, neoplasia of respiratory system,, pneumonia,, rhinitis and sinusitis., tonsilitis,. Allergic pneumonitis accounted for the largest share of this market in 2017 owing to its high prevalence among dogs and cats worldwide. Geographically, North America dominates the global small animals respiratory diseases treatment market followed by Europe due to increased spending on pet healthcare and growing demand for advanced veterinary care products in these regions.
Product Definition:
Small Animals Respiratory Diseases Treatment is a type of veterinary medicine that is used to treat respiratory diseases in small animals, such as dogs and cats. The importance of Small Animals Respiratory Diseases Treatment is that it can help to improve the health and quality of life for small animals who are suffering from respiratory diseases.
Anthelmintics:
Anthelmintics is a drug that blocks the antemeridian gland, which causes an increase in pressure within the sinuses and results in headache. The most commonly used anthelmintics are drugs such as aspirin, acetaminophen, and ibuprofen. Antipyrine is another drug used for treatment; it works by blocking pain signals to the brain.
Non-steroidal Anti-Inflammatory Drugs (NSAIDs):
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) are used to treat pain, reduce fever, and prevent damage to organs. They do not have any effect on the cure of diseases like antibiotics or corticosteroids. NSAIDs are available in various forms such as tablets, ointments, injections and oral gels.
Application Insights:
The global small animals respiratory diseases treatment market is segmented based on the application as allergic pneumonia, canine influenza, canine nasal mites, lung nematodes, neoplasia of respiratory system and pneumonia. The allergic pneumonia segment held the largest share in 2017 owing to increase in prevalence of allergies among pets resulting in increased number of visits to veterinarians for treatment. This trend is expected to continue over the forecast period due to rising awareness about preventive measures taken by pet owners against various types of infections.
Corticosteroids are used for treating inflammation caused due largelyto immune response against self-antigens present within body tissues or organs such as skin & mucous membranes. In addition, they exhibit anti-inflammatory properties that help reduce swelling caused by injury or disease process inside a cell membrane which results in reduction in pain & disability and improvementin quality Of life (QoL).
Regional Analysis:
North America dominated the global market in 2017. The presence of well-developed healthcare infrastructure, high adoption rate of advanced therapeutics for small animal diseases, and high disposable income are some factors responsible for its large share. Moreover, increasing demand for companion animals and rising awareness about pet health & hygiene contribute to the growth of this regional segment.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to a rise in disposable income resulting into an increase in spending on pets as well as livestock. This has resulted into increased demand for treatment options across this region which will further boost market development during the estimated period.
Growth Factors:
- Increasing prevalence of small animals respiratory diseases
- Growing awareness about small animals respiratory diseases and their treatment options
- Rising demand for better and more effective small animals respiratory disease treatments
- Technological advancements in the field of small animals respiratory disease treatment 5. Growing number of research and development activities focused on the development of new and improved small animals respiratory disease treatments
Scope Of The Report
Report Attributes
Report Details
Report Title
Small Animals Respiratory Diseases Treatment Market Research Report
By Type
Anthelmintics, Non-steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Antibiotics, Antihistamines, Phosphodiesterase (PDE) inhibitors, Bronchodilators, Antineoplastic Agents
By Application
Allergic Pneumonitis, Canine Influenza, Canine Nasal Mites, Lung Nematodes, Neoplasia Of Respiratory System, Pneumonia, Rhinitis And Sinusitis, Tonsilitis
By Companies
Zoetis, Inc., Merck Animal Health, Boehringer Ingelheim GmbH, Bayer AG, Ceva Animal Health, Vetoquinol SA, Virbac Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
141
Number of Tables & Figures
99
Customization Available
Yes, the report can be customized as per your need.
Global Small Animals Respiratory Diseases Treatment Market Report Segments:
The global Small Animals Respiratory Diseases Treatment market is segmented on the basis of:
Types
Anthelmintics, Non-steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Antibiotics, Antihistamines, Phosphodiesterase (PDE) inhibitors, Bronchodilators, Antineoplastic Agents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Allergic Pneumonitis, Canine Influenza, Canine Nasal Mites, Lung Nematodes, Neoplasia Of Respiratory System, Pneumonia, Rhinitis And Sinusitis, Tonsilitis
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zoetis, Inc.
- Merck Animal Health
- Boehringer Ingelheim GmbH
- Bayer AG
- Ceva Animal Health
- Vetoquinol SA
- Virbac Ltd.
Highlights of The Small Animals Respiratory Diseases Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anthelmintics
- Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
- Corticosteroids
- Antibiotics
- Antihistamines
- Phosphodiesterase (PDE) inhibitors
- Bronchodilators
- Antineoplastic Agents
- By Application:
- Allergic Pneumonitis
- Canine Influenza
- Canine Nasal Mites
- Lung Nematodes
- Neoplasia Of Respiratory System
- Pneumonia
- Rhinitis And Sinusitis
- Tonsilitis
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Small Animals Respiratory Diseases Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Small animals respiratory diseases treatment is the use of medications and other treatments to help a small animal with respiratory problems.
Some of the major companies in the small animals respiratory diseases treatment market are Zoetis, Inc., Merck Animal Health, Boehringer Ingelheim GmbH, Bayer AG, Ceva Animal Health, Vetoquinol SA, Virbac Ltd..
The small animals respiratory diseases treatment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Small Animals Respiratory Diseases Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Small Animals Respiratory Diseases Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Small Animals Respiratory Diseases Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Small Animals Respiratory Diseases Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Small Animals Respiratory Diseases Treatment Market Size & Forecast, 2018-2028
4.5.1 Small Animals Respiratory Diseases Treatment Market Size and Y-o-Y Growth
4.5.2 Small Animals Respiratory Diseases Treatment Market Absolute $ Opportunity
Chapter 5 Global Small Animals Respiratory Diseases Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Small Animals Respiratory Diseases Treatment Market Size Forecast by Type
5.2.1 Anthelmintics
5.2.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
5.2.3 Corticosteroids
5.2.4 Antibiotics
5.2.5 Antihistamines
5.2.6 Phosphodiesterase (PDE) inhibitors
5.2.7 Bronchodilators
5.2.8 Antineoplastic Agents
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Small Animals Respiratory Diseases Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Small Animals Respiratory Diseases Treatment Market Size Forecast by Applications
6.2.1 Allergic Pneumonitis
6.2.2 Canine Influenza
6.2.3 Canine Nasal Mites
6.2.4 Lung Nematodes
6.2.5 Neoplasia Of Respiratory System
6.2.6 Pneumonia
6.2.7 Rhinitis And Sinusitis
6.2.8 Tonsilitis
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Small Animals Respiratory Diseases Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Small Animals Respiratory Diseases Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Small Animals Respiratory Diseases Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Small Animals Respiratory Diseases Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Small Animals Respiratory Diseases Treatment Market Size Forecast by Type
9.6.1 Anthelmintics
9.6.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
9.6.3 Corticosteroids
9.6.4 Antibiotics
9.6.5 Antihistamines
9.6.6 Phosphodiesterase (PDE) inhibitors
9.6.7 Bronchodilators
9.6.8 Antineoplastic Agents
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Small Animals Respiratory Diseases Treatment Market Size Forecast by Applications
9.10.1 Allergic Pneumonitis
9.10.2 Canine Influenza
9.10.3 Canine Nasal Mites
9.10.4 Lung Nematodes
9.10.5 Neoplasia Of Respiratory System
9.10.6 Pneumonia
9.10.7 Rhinitis And Sinusitis
9.10.8 Tonsilitis
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Small Animals Respiratory Diseases Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Small Animals Respiratory Diseases Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Small Animals Respiratory Diseases Treatment Market Size Forecast by Type
10.6.1 Anthelmintics
10.6.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
10.6.3 Corticosteroids
10.6.4 Antibiotics
10.6.5 Antihistamines
10.6.6 Phosphodiesterase (PDE) inhibitors
10.6.7 Bronchodilators
10.6.8 Antineoplastic Agents
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Small Animals Respiratory Diseases Treatment Market Size Forecast by Applications
10.10.1 Allergic Pneumonitis
10.10.2 Canine Influenza
10.10.3 Canine Nasal Mites
10.10.4 Lung Nematodes
10.10.5 Neoplasia Of Respiratory System
10.10.6 Pneumonia
10.10.7 Rhinitis And Sinusitis
10.10.8 Tonsilitis
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Small Animals Respiratory Diseases Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Small Animals Respiratory Diseases Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Small Animals Respiratory Diseases Treatment Market Size Forecast by Type
11.6.1 Anthelmintics
11.6.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
11.6.3 Corticosteroids
11.6.4 Antibiotics
11.6.5 Antihistamines
11.6.6 Phosphodiesterase (PDE) inhibitors
11.6.7 Bronchodilators
11.6.8 Antineoplastic Agents
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Small Animals Respiratory Diseases Treatment Market Size Forecast by Applications
11.10.1 Allergic Pneumonitis
11.10.2 Canine Influenza
11.10.3 Canine Nasal Mites
11.10.4 Lung Nematodes
11.10.5 Neoplasia Of Respiratory System
11.10.6 Pneumonia
11.10.7 Rhinitis And Sinusitis
11.10.8 Tonsilitis
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Small Animals Respiratory Diseases Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Small Animals Respiratory Diseases Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Small Animals Respiratory Diseases Treatment Market Size Forecast by Type
12.6.1 Anthelmintics
12.6.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
12.6.3 Corticosteroids
12.6.4 Antibiotics
12.6.5 Antihistamines
12.6.6 Phosphodiesterase (PDE) inhibitors
12.6.7 Bronchodilators
12.6.8 Antineoplastic Agents
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Small Animals Respiratory Diseases Treatment Market Size Forecast by Applications
12.10.1 Allergic Pneumonitis
12.10.2 Canine Influenza
12.10.3 Canine Nasal Mites
12.10.4 Lung Nematodes
12.10.5 Neoplasia Of Respiratory System
12.10.6 Pneumonia
12.10.7 Rhinitis And Sinusitis
12.10.8 Tonsilitis
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Small Animals Respiratory Diseases Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Small Animals Respiratory Diseases Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Small Animals Respiratory Diseases Treatment Market Size Forecast by Type
13.6.1 Anthelmintics
13.6.2 Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
13.6.3 Corticosteroids
13.6.4 Antibiotics
13.6.5 Antihistamines
13.6.6 Phosphodiesterase (PDE) inhibitors
13.6.7 Bronchodilators
13.6.8 Antineoplastic Agents
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Small Animals Respiratory Diseases Treatment Market Size Forecast by Applications
13.10.1 Allergic Pneumonitis
13.10.2 Canine Influenza
13.10.3 Canine Nasal Mites
13.10.4 Lung Nematodes
13.10.5 Neoplasia Of Respiratory System
13.10.6 Pneumonia
13.10.7 Rhinitis And Sinusitis
13.10.8 Tonsilitis
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Small Animals Respiratory Diseases Treatment Market: Competitive Dashboard
14.2 Global Small Animals Respiratory Diseases Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Zoetis, Inc.
14.3.2 Merck Animal Health
14.3.3 Boehringer Ingelheim GmbH
14.3.4 Bayer AG
14.3.5 Ceva Animal Health
14.3.6 Vetoquinol SA
14.3.7 Virbac Ltd.
